X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs JUBILANT LIFE SCIENCES - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD JUBILANT LIFE SCIENCES MERCK LTD/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 34.2 26.9 127.2% View Chart
P/BV x 3.8 5.5 69.3% View Chart
Dividend Yield % 0.7 0.3 224.3%  

Financials

 MERCK LTD   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    MERCK LTD
Dec-16
JUBILANT LIFE SCIENCES
Mar-14
MERCK LTD/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,060187 567.5%   
Low Rs62365 957.0%   
Sales per share (Unadj.) Rs632.4364.3 173.6%  
Earnings per share (Unadj.) Rs45.76.8 667.8%  
Cash flow per share (Unadj.) Rs62.324.5 254.4%  
Dividends per share (Unadj.) Rs11.003.00 366.7%  
Dividend yield (eoy) %1.32.4 54.9%  
Book value per share (Unadj.) Rs388.8164.9 235.8%  
Shares outstanding (eoy) m16.60159.28 10.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.3 384.9%   
Avg P/E ratio x18.418.4 100.0%  
P/CF ratio (eoy) x13.55.1 262.7%  
Price / Book Value ratio x2.20.8 283.3%  
Dividend payout %24.143.8 54.9%   
Avg Mkt Cap Rs m13,96920,061 69.6%   
No. of employees `0001.66.2 25.6%   
Total wages/salary Rs m1,48711,052 13.5%   
Avg. sales/employee Rs Th6,631.99,383.0 70.7%   
Avg. wages/employee Rs Th939.21,786.9 52.6%   
Avg. net profit/employee Rs Th479.4176.3 271.9%   
INCOME DATA
Net Sales Rs m10,49858,034 18.1%  
Other income Rs m242191 127.2%   
Total revenues Rs m10,74158,224 18.4%   
Gross profit Rs m1,1355,786 19.6%  
Depreciation Rs m2762,812 9.8%   
Interest Rs m03,237 0.0%   
Profit before tax Rs m1,102-72 -1,528.7%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m343696 49.3%   
Profit after tax Rs m7591,090 69.6%  
Gross profit margin %10.810.0 108.5%  
Effective tax rate %31.1-965.9 -3.2%   
Net profit margin %7.21.9 384.7%  
BALANCE SHEET DATA
Current assets Rs m6,41029,280 21.9%   
Current liabilities Rs m8,82838,912 22.7%   
Net working cap to sales %-23.0-16.6 138.8%  
Current ratio x0.70.8 96.5%  
Inventory Days Days5884 68.4%  
Debtors Days Days3851 75.7%  
Net fixed assets Rs m1,40655,712 2.5%   
Share capital Rs m166155 107.4%   
"Free" reserves Rs m6,28620,968 30.0%   
Net worth Rs m6,45526,265 24.6%   
Long term debt Rs m017,169 0.0%   
Total assets Rs m8,82888,606 10.0%  
Interest coverage xNM1.0-  
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x1.20.7 181.6%   
Return on assets %8.64.9 176.0%  
Return on equity %11.84.2 283.2%  
Return on capital %17.111.6 147.6%  
Exports to sales %8.337.8 21.9%   
Imports to sales %21.016.5 127.6%   
Exports (fob) Rs m86921,933 4.0%   
Imports (cif) Rs m2,2099,567 23.1%   
Fx inflow Rs m95922,004 4.4%   
Fx outflow Rs m2,61211,749 22.2%   
Net fx Rs m-1,65310,255 -16.1%   
CASH FLOW
From Operations Rs m1,0708,026 13.3%  
From Investments Rs m-750-1,744 43.0%  
From Financial Activity Rs m-150-4,447 3.4%  
Net Cashflow Rs m1711,834 9.3%  

Share Holding

Indian Promoters % 0.0 45.6 -  
Foreign collaborators % 51.8 3.5 1,480.0%  
Indian inst/Mut Fund % 18.2 8.7 209.2%  
FIIs % 1.0 21.2 4.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 21.1 137.9%  
Shareholders   28,591 23,815 120.1%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   PFIZER  GSK PHARMA  PLETHICO PHARMA  STERLING BIOTECH  ASTRAZENECA PHARMA  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 24, 2018 02:53 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS